WINTON GROUP Ltd Has $859,000 Stake in Core Laboratories Inc. (NYSE:CLB)

WINTON GROUP Ltd lifted its position in shares of Core Laboratories Inc. (NYSE:CLB) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,623 shares of the oil and gas company’s stock after buying an additional 2,683 shares during the period. WINTON GROUP Ltd owned about 0.11% of Core Laboratories worth $859,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp boosted its stake in shares of Core Laboratories by 2.9% during the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after buying an additional 56,187 shares during the last quarter. Geode Capital Management LLC grew its stake in Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock valued at $19,521,000 after purchasing an additional 7,721 shares in the last quarter. Boston Trust Walden Corp increased its position in shares of Core Laboratories by 2.7% during the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock worth $10,686,000 after purchasing an additional 16,503 shares during the last quarter. Barclays PLC raised its stake in shares of Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after purchasing an additional 62,042 shares in the last quarter. Finally, Amundi boosted its holdings in shares of Core Laboratories by 194.8% in the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company’s stock valued at $600,000 after buying an additional 21,783 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Analyst Ratings Changes

Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and upped their price target for the stock from $15.00 to $16.00 in a research report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, Core Laboratories presently has a consensus rating of “Hold” and an average price target of $17.50.

Core Laboratories Stock Down 1.4 %

CLB opened at $15.30 on Friday. The stock’s fifty day simple moving average is $16.44 and its 200 day simple moving average is $18.10. Core Laboratories Inc. has a 1-year low of $12.95 and a 1-year high of $25.13. The stock has a market cap of $716.45 million, a PE ratio of 23.18, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. As a group, research analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date was Monday, February 10th. Core Laboratories’s dividend payout ratio is presently 6.06%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.